.jpg?format=webp&width=780)
Olfactory dysfunction is a recognized manifestation in patients infected with COVID‐19. This investigation is aimed to assess the effect of mometasone furoate intranasal spray on the improvement of smell dysfunction in post‐COVID‐19 patients.
Like
Save
Share